糖尿病足的药物治疗进展

www.yongyao.net　　2009-8-24 15:31:17　　来源：　　责任编辑：

分享到：

[参考文献]
[ 1 ] 　APELQV IST J. Wound healing in diabetes: outcome and costs[ J ].Clin PediatrM ed Sur, 1998, 15 (1) : 21 - 25.
[ 2 ] 　BREM H, SHEEHAN P, BOULTON A J . Protocol for treatment of diabetic foot ulcers[ J ]. Am J Surg, 2004, 187 (5A) : 1S.
[ 3 ] 　BOWER ING C K. Diabetic foot ulcers. Pathophysiology, assessment and therapy[ J ]. Can Fam Physician, 2001, 47 (10) : 1007 - 1011.
[ 4 ] 　CUNHA B A. Antibiotic selection for diabetic foot infections : areview[ J ]. J Foot Ankle Surg, 2000, 39 (4) : 253 - 254.
[ 5 ] 　STEED D L. Foundations of good ulcer care[ J ]. Am J Surg, 1998,176 (2A Supp l) : 20S .
[ 6 ] 　魏　亮,方丽霞. MEBO +胰岛素治疗顽固性糖尿病患者皮肤溃疡体会[ J ]. 中国烧伤疮疡杂志, 2005, 17 (1) : 53 - 54.
[ 7 ] 　蒋谷芬,贺　霞,罗香娇. 胰岛素外用加九华膏外敷治疗糖尿病足底溃疡60例[ J ]. 中国中医药信息杂志, 2005, 12 ( 4 ) : 61 -62.
[ 8 ] 　李雯霞,朱旭萍. 辛伐他汀对2型糖尿病并发冠心病患者血管内皮功能的影响[ J ]. 中国现代医学杂志, 2003, 13 (6) : 60 - 61.
[ 9 ] 　薛　浩,彭应心. 血管紧张肽转换酶抑制药和β2受体阻滞药对原发性高血压疗效观察[ J ]. 中国临床康复, 2004, 8 ( 24) : 5024 -5025.
[ 10 ] 　冯　毅,陈少颖,梁干雄. 前列腺素E1治疗糖尿病足疗效观察[ J ]. 实用糖尿病杂志, 2005, 1 (6) : 35.
[ 11 ] 　卢筱华,冯　烈. 川芎嗪和山莨菪碱治疗糖尿病足疗效观察[ J ]. 广州医药, 2005, 32 (1) : 19 - 20.
[ 12 ] 　刘彩艳,魏　健. 低分子量肝素钠治疗糖尿病足溃疡的疗效观察[ J ]. 实用医药杂志, 2004, 5 (21) : 432 - 433.
[ 13 ] 　郭行端,叶志东,刘君海,等. 糖尿病足抗凝血及降低血液黏度药物治疗的研究[ J ]. 新医学, 2005, 3 (36) : 158 - 160.
[ 14 ] 　康胜群,赵淑健,宋庆芳. 西洛他唑治疗2型糖尿病下肢血管病变的临床观察[ J ]. 临床荟萃, 2004, 19 (22) : 1298.
[ 15 ] 　邱　阳,张　锦,翟秀岩,等. 神经生长因子对糖尿病大鼠坐骨神经形态学的影响[ J ]. 中华老年医学杂志, 2003, 22 ( 8) : 486 -487.
[ 16 ] 　殷寒秋,殷松楼,张　锦,等. 甲钴胺在糖尿病足治疗中的应用[ J ]. 徐州医学院学报, 2001, 21 (6) : 509 - 510.
[ 17 ] 　AMETOV A S, BAR INOV A, DYCK P J, et al. The sensory symp toms of diabetic polyneuropathy are imp roved withα2lipoic acid: the sydney trial[ J ]. D iabetes Care, 2003, 26 (3) : 770 - 772.
[ 18 ] 　KAWAMURA M,OHARA H, GO K, et al. Neurotrop in induces antinocicep tive effect by enhancing descending pain inhibitory systems involving 52HT3 and noradr energic alpha 2 recep tors in sp inal dorsalhorn[ J ]. L ife Sci, 1998, 62 (12) : 2181 - 2190.
[ 19 ] 　HOTTA N, KOH N, SAKAKIBARA F, et al. Neurotrop in p revents neurophysiological abnormalities and ADP2induced hyperaggregability in rats with strep tozotocin2induced diabetes [ J ].L ife Sci, 1995, 57 (12) : 2101 - 2111.
[ 20 ] 　宁　光,邹大进,刘　伟,等. 神经妥乐平治疗糖尿病神经病变的多中心研究[ J ]. 中华医学杂志, 2004, 84 (11) : 1785 - 1788.
[ 21 ] 　赵秀敏,董淑惠. 卡马西平治疗糖尿病周围神经性病变疼痛疗效观察[ J ]. 中国误诊学杂志, 2006, 3 (6) : 867 - 868.
[ 22 ] 　HOTTA N, TOYOTA T,MATSUOKA K, et al. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 522week multicenter p lacebo2controlled double2blind parallel group study [ J ]. D iabetes Care, 2001, 24 ( 10 ) : 1776 -1780.
[ 23 ] 　汤正义,陈宇红,张连珍,等. 依帕司他和甲钴胺治疗糖尿病性神经病变疗效的比较[ J ]. 世界临床药物, 2003, 24 (9) : 539 - 540.
[ 24 ] 　JOSEPH W S, LEFROCK J L. The pathogenesis of diabetic foot infections immunopathy, angiopathy and neuropathy [ J ]. J Foot Surgy, 1987, 26 (1) : S 7.
[ 25 ] 　AXLER D A. Microbiology of diabetic foot infections [ J ]. J Foot Surgy, 1987, 26 (1) : S 3.
[ 26 ] 　WHEATL J,A LLEN SD, HENRYM, et al. Diabetic foot infections[ J ]. A rch Intern M ed, 1986, 146 (12) : 1935 - 1940.
[ 27 ] 　N IX D E, CUMBO T J, KUR ITZKY P, et al. Oral cip rofloxacin in the treatment of serious soft tissue and bone infections [ J ]. Am JMed, 1987, 82 (14 ) : 46 - 47.
[ 28 ] 　郑宏庭,方　芳,陈　卫,等. 重组牛碱性成纤维细胞生长因子治疗糖尿病足: 随机对照疗效观察[ J ]. 中国临床康复, 2004, 30(8) : 6564 - 6566.